Jiang Tao, Jiang Jing, Zhou Yang, Zhao Gui-Qiu, Li Hui, Zhao Shan-Yao
Department of Ophthalmology, the Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003, Shandong Province, China.
Int J Ophthalmol. 2011;4(5):513-8. doi: 10.3980/j.issn.2222-3959.2011.05.11. Epub 2011 Oct 18.
To evaluate the effects and safety of phacoemulsification (Phaco) or small-incision extracapsular cataract surgery (SICS) and intraocular lens (IOL) implantation for aged patients.
Totally 137 aged patients (149 eyes) underwent cataract operation in the case of stable systemic condition, the blood pressure less than 160/95mmHg, blood glucose less than 8mmol/L, and under the help of electrocardiogram surveillance by anesthesiologists during the operation. 106 aged patients (114 eyes) underwent Phaco while 31 aged patients (35 eyes) underwent SICS. The postoperative visual acuity, corneal endothelial cell loss, surgery time and major complications were observed and analyzed retrospectively.
The best-corrected visual acuity(BCVA) of ≥0.6 was achieved in 135 eyes (92.6%) at 1 month postoperatively (χ(2)=259.730, P<0.001). For aged patients, both Phaco and SICS could significantly improve visual acuity with no significant difference (χ(2)=4.535, P>0.05). Postoperative corneal endothelial cell loss was 18.6%, in PHACO group, the rate was 18.5%; in SICS group, the rate was 19.0%, the difference of which was no significant (χ(2)=0.102, P>0.05). The surgery time was different in two groups. No severe complications occurred.
Both Phaco and SICS combined with IOL implantation for aged patients are effective and safe. Before surgery, detailed physical examination should be performed. When the systemic condition is stable, cataract surgery for aged patients is safe.
评估超声乳化白内障吸除术(Phaco)或小切口白内障囊外摘除术(SICS)联合人工晶状体(IOL)植入术治疗老年患者的疗效及安全性。
137例老年患者(149只眼)在全身状况稳定、血压低于160/95mmHg、血糖低于8mmol/L且术中在麻醉医师心电图监测帮助下接受白内障手术。106例老年患者(114只眼)接受Phaco手术,31例老年患者(35只眼)接受SICS手术。回顾性观察并分析术后视力、角膜内皮细胞损失、手术时间及主要并发症。
术后1个月时135只眼(92.6%)最佳矫正视力(BCVA)≥0.6(χ(2)=259.730,P<0.001)。对于老年患者,Phaco和SICS均可显著提高视力,差异无统计学意义(χ(2)=4.535,P>0.05)。术后角膜内皮细胞损失率为18.6%,Phaco组为18.5%;SICS组为19.0%,差异无统计学意义(χ(2)=0.102,P>0.05)。两组手术时间不同。未发生严重并发症。
Phaco和SICS联合IOL植入术治疗老年患者均有效且安全。手术前应进行详细体格检查。当全身状况稳定时,老年患者白内障手术是安全的。